# Pentoxifylline in the Treatment of NEC in Premature Neonates

> **NCT00271336** · PHASE2 · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Necrotizing Enterocolitis

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT00271336
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** 2009-03
- **Final completion:** 2010-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271336, "Pentoxifylline in the Treatment of NEC in Premature Neonates". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00271336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*